Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-25-001464
Filing Date
2025-03-10
Accepted
2025-03-10 16:17:22
Documents
5
Period of Report
2025-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT pharmacyte_def14a.htm DEF 14A 298560
2 GRAPHIC image_001.jpg GRAPHIC 189093
3 GRAPHIC image_002.jpg GRAPHIC 34923
4 GRAPHIC image_003.jpg GRAPHIC 134404
5 GRAPHIC image_004.jpg GRAPHIC 88146
  Complete submission text file 0001683168-25-001464.txt   915402
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-40699 | Film No.: 25723924
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)